Charles Schwab Investment Management Inc 89bio, Inc. Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in 89bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 810,826 shares of ETNB stock, worth $5.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

810,826

Previous 721,050 12.45%

Holding current value

$5.61 Million

Previous $5.34 Million 16.57%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$7.03 - $10.05 $631,125 - $902,248	89,776 Added 12.45%	810,826 $6.22 Million
Q3 2024 Nov 12, 2024	BUY	$7.36 - $9.66 $396,939 - $520,983	53,932 Added 8.08%	721,050 $5.34 Million
Q2 2024 Aug 12, 2024	BUY	$7.31 - $10.9 $276,939 - $412,946	37,885 Added 6.02%	667,118 $5.34 Million
Q1 2024 May 08, 2024	BUY	$8.13 - $13.77 $1.06 Million - $1.79 Million	129,880 Added 26.01%	629,233 $7.32 Million
Q4 2023 Feb 06, 2024	BUY	$6.66 - $16.03 $68,924 - $165,894	10,349 Added 2.12%	499,353 $5.58 Million
Q3 2023 Nov 08, 2023	BUY	$15.06 - $19.41 $4.85 Million - $6.26 Million	322,339 Added 193.41%	489,004 $7.55 Million
Q2 2023 Aug 09, 2023	BUY	$14.15 - $22.03 $2.06 Million - $3.21 Million	145,639 Added 692.66%	166,665 $3.16 Million
Q1 2023 May 11, 2023	BUY	$10.48 - $16.94 $59,987 - $96,964	5,724 Added 37.41%	21,026 $320,000
Q3 2022 Nov 14, 2022	BUY	$3.02 - $7.0 $46,212 - $107,114	15,302 New	15,302 $89,000
Q2 2022 Aug 15, 2022	SELL	$2.09 - $4.02 $43,185 - $83,065	-20,663 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$3.45 - $14.99 $14,303 - $62,148	-4,146 Reduced 16.71%	20,663 $78,000
Q3 2021 Nov 16, 2021	SELL	$14.91 - $21.31 $567,131 - $810,568	-38,037 Reduced 60.52%	24,809 $487,000
Q2 2021 Aug 16, 2021	BUY	$17.42 - $28.0 $60,377 - $97,048	3,466 Added 5.84%	62,846 $1.18 Million
Q1 2021 May 17, 2021	BUY	$20.22 - $26.73 $93,598 - $123,733	4,629 Added 8.45%	59,380 $1.41 Million
Q4 2020 Feb 16, 2021	BUY	$23.16 - $28.08 $340,521 - $412,860	14,703 Added 36.71%	54,751 $1.34 Million
Q3 2020 Nov 13, 2020	BUY	$24.34 - $38.82 $213,267 - $340,140	8,762 Added 28.01%	40,048 $1.03 Million
Q2 2020 Aug 14, 2020	BUY	$19.93 - $31.2 $49,446 - $77,407	2,481 Added 8.61%	31,286 $624,000
Q1 2020 May 15, 2020	BUY	$16.4 - $41.77 $7,691 - $19,590	469 Added 1.66%	28,805 $728,000
Q4 2019 Feb 07, 2020	BUY	$19.75 - $33.44 $559,636 - $947,555	28,336 New	28,336 $745,000

Others Institutions Holding ETNB

# of Institutions

173

Shares Held

125M

Call Options Held

78.7K

Put Options Held

979K

View Full List

About 89bio, Inc.

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $322M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

More about ETNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc 89bio, Inc. Transaction History